Deer
Taxonomy: Cellular organisms; Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata; Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota; Mammalia; Theria; Eutheria; Boreoeutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora,
Latin Name:
Cervus nippon
Tested tissues: Lung, PBMC,
Data set information
| Project | Date | Technology | Tissue | Condition | Cell | PMID/DOI |
|---|---|---|---|---|---|---|
| Vthunter_0044 | 2021.04 | 10X Genomics | Lung | Normal | 19662 | Link |
| Vthunter_100006 | 2021.05 | iDrop | PBMC | Normal | 3306 | Link |
| Virus | Virus Name | GeneTop 5 cell types expressing viral receptor ordered by expression proportion |
|---|---|---|
|
Hendra henipavirus |
Lung-Fibroblasts : 77.57% ; Lung-Endothelial cells : 75.94% ; Lung-Secretory cells : 75.58% ; Lung-ATI : 62.60% ; Lung-Ciliated cells : 62.50% ; |
|
Nipah henipavirus |
Lung-Fibroblasts : 77.57% ; Lung-Endothelial cells : 75.94% ; Lung-Secretory cells : 75.58% ; Lung-ATI : 62.60% ; Lung-Ciliated cells : 62.50% ; |
|
Severe acute respiratory syndrome coronavirus 2 |
Lung-Fibroblasts : 74.45% ; Lung-Secretory cells : 60.90% ; Lung-ATI : 56.35% ; Lung-Macrophages : 54.61% ; Lung-Endothelial cells : 51.72% ; Lung-Fibroblasts : 24.14% ; Lung-Secretory cells : 14.99% ; Lung-Endothelial cells : 12.22% ; Lung-Ciliated cells : 10.66% ; Lung-Macrophages : 10.47% ; Lung-Macrophages : 11.80% ; Lung-Fibroblasts : 7.04% ; |
|
Human alphaherpesvirus 1 |
Lung-Secretory cells : 71.49% ; Lung-ATI : 53.60% ; Lung-ATII : 39.38% ; Lung-T cells : 33.33% ; Lung-B cells : 32.86% ; Lung-Secretory cells : 51.89% ; Lung-Fibroblasts : 35.93% ; Lung-ATI : 34.55% ; Lung-T cells : 33.33% ; Lung-Ciliated cells : 24.34% ; Lung-Ciliated cells : 27.63% ; Lung-Fibroblasts : 21.06% ; Lung-ATI : 18.60% ; Lung-Secretory cells : 15.62% ; Lung-ATII : 9.07% ; |
|
Coxsackievirus A9 | |
|
Coxsackievirus B1 |
Lung-Secretory cells : 71.49% ; Lung-ATI : 53.60% ; Lung-ATII : 39.38% ; Lung-T cells : 33.33% ; Lung-B cells : 32.86% ; Lung-Ciliated cells : 52.11% ; Lung-Secretory cells : 50.31% ; Lung-ATI : 42.10% ; Lung-Fibroblasts : 32.76% ; Lung-ATII : 30.85% ; Lung-Secretory cells : 51.89% ; Lung-Fibroblasts : 35.93% ; Lung-ATI : 34.55% ; Lung-T cells : 33.33% ; Lung-Ciliated cells : 24.34% ; Lung-Secretory cells : 31.87% ; Lung-ATI : 28.70% ; Lung-ATII : 17.90% ; Lung-Fibroblasts : 15.39% ; Lung-Ciliated cells : 14.34% ; |
|
Foot-and-mouth disease virus |
Lung-Secretory cells : 71.49% ; Lung-ATI : 53.60% ; Lung-ATII : 39.38% ; Lung-T cells : 33.33% ; Lung-B cells : 32.86% ; Lung-T cells : 66.67% ; Lung-Secretory cells : 53.77% ; Lung-Fibroblasts : 51.58% ; Lung-ATI : 42.65% ; Lung-Macrophages : 36.64% ; Lung-Secretory cells : 51.89% ; Lung-Fibroblasts : 35.93% ; Lung-ATI : 34.55% ; Lung-T cells : 33.33% ; Lung-Ciliated cells : 24.34% ; Lung-Ciliated cells : 27.63% ; Lung-Fibroblasts : 21.06% ; Lung-ATI : 18.60% ; Lung-Secretory cells : 15.62% ; Lung-ATII : 9.07% ; Lung-Fibroblasts : 6.46% ; Lung-Macrophages : 4.53% ; Lung-Endothelial cells : 4.09% ; |
|
Simian rotavirus A strain RRV |
Lung-T cells : 66.67% ; Lung-Secretory cells : 53.77% ; Lung-Fibroblasts : 51.58% ; Lung-ATI : 42.65% ; Lung-Macrophages : 36.64% ; Lung-T cells : 66.67% ; Lung-Secretory cells : 30.50% ; Lung-Fibroblasts : 23.53% ; Lung-ATI : 21.85% ; Lung-Ciliated cells : 19.61% ; Lung-Secretory cells : 51.89% ; Lung-Fibroblasts : 35.93% ; Lung-ATI : 34.55% ; Lung-T cells : 33.33% ; Lung-Ciliated cells : 24.34% ; Lung-Secretory cells : 44.44% ; Lung-ATI : 41.10% ; Lung-Ciliated cells : 40.92% ; Lung-Endothelial cells : 31.32% ; Lung-ATII : 30.59% ; |
|
Chikungunya virus |
Lung-T cells : 66.67% ; Lung-Secretory cells : 47.48% ; Lung-ATI : 42.00% ; Lung-Fibroblasts : 40.90% ; Lung-Ciliated cells : 40.66% ; |
|
Influenza A virus |
Lung-T cells : 66.67% ; Lung-Fibroblasts : 55.58% ; Lung-Ciliated cells : 49.74% ; Lung-Secretory cells : 49.16% ; Lung-Endothelial cells : 46.86% ; Lung-Secretory cells : 61.22% ; Lung-Fibroblasts : 51.45% ; Lung-ATI : 45.35% ; Lung-ATII : 38.01% ; Lung-T cells : 33.33% ; Lung-Fibroblasts : 61.21% ; Lung-Macrophages : 22.97% ; Lung-Ciliated cells : 18.29% ; Lung-Secretory cells : 16.56% ; Lung-Endothelial cells : 15.17% ; Lung-Ciliated cells : 34.61% ; Lung-Secretory cells : 30.19% ; Lung-ATI : 29.90% ; Lung-Fibroblasts : 24.27% ; Lung-Macrophages : 21.02% ; |
|
Echovirus E8 |
Lung-T cells : 66.67% ; Lung-Secretory cells : 53.77% ; Lung-Fibroblasts : 51.58% ; Lung-ATI : 42.65% ; Lung-Macrophages : 36.64% ; |
|
Mammalian orthoreovirus | |
|
Equid alphaherpesvirus 1 | |
|
Vesicular stomatitis virus | |
|
Human betaherpesvirus 5 |
Lung-T cells : 66.67% ; Lung-Secretory cells : 53.77% ; Lung-Fibroblasts : 51.58% ; Lung-ATI : 42.65% ; Lung-Macrophages : 36.64% ; Lung-Secretory cells : 61.22% ; Lung-Fibroblasts : 51.45% ; Lung-ATI : 45.35% ; Lung-ATII : 38.01% ; Lung-T cells : 33.33% ; Lung-Secretory cells : 51.89% ; Lung-Fibroblasts : 35.93% ; Lung-ATI : 34.55% ; Lung-T cells : 33.33% ; Lung-Ciliated cells : 24.34% ; |
|
Human rotavirus strain WA | |
|
Echovirus E1 |
Lung-T cells : 66.67% ; Lung-Secretory cells : 53.77% ; Lung-Fibroblasts : 51.58% ; Lung-ATI : 42.65% ; Lung-Macrophages : 36.64% ; |
|
Human metapneumovirus | |
|
Human parvovirus B19 | |
|
Adeno-associated virus - 2 |
Lung-T cells : 66.67% ; Lung-Secretory cells : 53.77% ; Lung-Fibroblasts : 51.58% ; Lung-ATI : 42.65% ; Lung-Macrophages : 36.64% ; Lung-Secretory cells : 24.21% ; Lung-ATI : 19.50% ; Lung-Ciliated cells : 17.37% ; Lung-Fibroblasts : 16.67% ; Lung-ATII : 10.95% ; Lung-Fibroblasts : 8.53% ; Lung-Secretory cells : 8.39% ; Lung-ATI : 6.90% ; Lung-ATII : 6.59% ; Lung-Endothelial cells : 6.15% ; Lung-Fibroblasts : 6.46% ; Lung-Macrophages : 4.53% ; Lung-Endothelial cells : 4.09% ; |
|
Human gammaherpesvirus 4 | |
|
Rhinovirus C |
Lung-Ciliated cells : 61.32% ; Lung-ATI : 8.50% ; Lung-Fibroblasts : 4.22% ; |
|
Hepacivirus C |
Lung-Secretory cells : 61.22% ; Lung-Fibroblasts : 51.45% ; Lung-ATI : 45.35% ; Lung-ATII : 38.01% ; Lung-T cells : 33.33% ; Lung-T cells : 33.33% ; Lung-Secretory cells : 24.42% ; Lung-ATI : 13.60% ; Lung-Fibroblasts : 11.65% ; Lung-ATII : 10.53% ; Lung-T cells : 33.33% ; Lung-Secretory cells : 18.97% ; Lung-ATI : 11.15% ; Lung-ATII : 6.07% ; Lung-Ciliated cells : 5.79% ; Lung-Fibroblasts : 24.14% ; Lung-Secretory cells : 14.99% ; Lung-Endothelial cells : 12.22% ; Lung-Ciliated cells : 10.66% ; Lung-Macrophages : 10.47% ; Lung-Secretory cells : 16.56% ; Lung-Fibroblasts : 9.15% ; Lung-ATI : 6.55% ; Lung-ATII : 5.44% ; Lung-Macrophages : 5.31% ; Lung-Macrophages : 7.03% ; Lung-Secretory cells : 6.81% ; Lung-Fibroblasts : 6.55% ; |
|
Coxsackievirus A10 |
Lung-Secretory cells : 58.80% ; Lung-ATI : 54.15% ; Lung-Ciliated cells : 39.21% ; Lung-ATII : 36.61% ; Lung-B cells : 35.22% ; |
|
Echovirus E7 |
Lung-Ciliated cells : 52.11% ; Lung-Secretory cells : 50.31% ; Lung-ATI : 42.10% ; Lung-Fibroblasts : 32.76% ; Lung-ATII : 30.85% ; |
|
Echovirus E21 |
Lung-Ciliated cells : 52.11% ; Lung-Secretory cells : 50.31% ; Lung-ATI : 42.10% ; Lung-Fibroblasts : 32.76% ; Lung-ATII : 30.85% ; |
|
Human enterovirus 70 |
Lung-Ciliated cells : 52.11% ; Lung-Secretory cells : 50.31% ; Lung-ATI : 42.10% ; Lung-Fibroblasts : 32.76% ; Lung-ATII : 30.85% ; |
|
Echovirus E29 |
Lung-Ciliated cells : 52.11% ; Lung-Secretory cells : 50.31% ; Lung-ATI : 42.10% ; Lung-Fibroblasts : 32.76% ; Lung-ATII : 30.85% ; |
|
Coxsackievirus B5 | |
|
Echovirus E6 |
Lung-Ciliated cells : 52.11% ; Lung-Secretory cells : 50.31% ; Lung-ATI : 42.10% ; Lung-Fibroblasts : 32.76% ; Lung-ATII : 30.85% ; |
|
Coxsackievirus A21 |
Lung-Ciliated cells : 52.11% ; Lung-Secretory cells : 50.31% ; Lung-ATI : 42.10% ; Lung-Fibroblasts : 32.76% ; Lung-ATII : 30.85% ; |
|
Echovirus E13 |
Lung-Ciliated cells : 52.11% ; Lung-Secretory cells : 50.31% ; Lung-ATI : 42.10% ; Lung-Fibroblasts : 32.76% ; Lung-ATII : 30.85% ; |
|
Echovirus E33 |
Lung-Ciliated cells : 52.11% ; Lung-Secretory cells : 50.31% ; Lung-ATI : 42.10% ; Lung-Fibroblasts : 32.76% ; Lung-ATII : 30.85% ; |
|
Enterovirus D68 |
Lung-Ciliated cells : 52.11% ; Lung-Secretory cells : 50.31% ; Lung-ATI : 42.10% ; Lung-Fibroblasts : 32.76% ; Lung-ATII : 30.85% ; |
|
Coxsackievirus B3 | |
|
Echovirus E12 |
Lung-Ciliated cells : 52.11% ; Lung-Secretory cells : 50.31% ; Lung-ATI : 42.10% ; Lung-Fibroblasts : 32.76% ; Lung-ATII : 30.85% ; |
|
Echovirus E20 |
Lung-Ciliated cells : 52.11% ; Lung-Secretory cells : 50.31% ; Lung-ATI : 42.10% ; Lung-Fibroblasts : 32.76% ; Lung-ATII : 30.85% ; |
|
Echovirus E11 |
Lung-Ciliated cells : 52.11% ; Lung-Secretory cells : 50.31% ; Lung-ATI : 42.10% ; Lung-Fibroblasts : 32.76% ; Lung-ATII : 30.85% ; |
|
Human parechovirus 1 |
Lung-Secretory cells : 51.89% ; Lung-Fibroblasts : 35.93% ; Lung-ATI : 34.55% ; Lung-T cells : 33.33% ; Lung-Ciliated cells : 24.34% ; |
|
West Nile virus |
Lung-Secretory cells : 51.89% ; Lung-Fibroblasts : 35.93% ; Lung-ATI : 34.55% ; Lung-T cells : 33.33% ; Lung-Ciliated cells : 24.34% ; |
|
Human gammaherpesvirus 8 |
Lung-Secretory cells : 51.89% ; Lung-Fibroblasts : 35.93% ; Lung-ATI : 34.55% ; Lung-T cells : 33.33% ; Lung-Ciliated cells : 24.34% ; |
|
Human mastadenovirus C |
Lung-Secretory cells : 51.89% ; Lung-Fibroblasts : 35.93% ; Lung-ATI : 34.55% ; Lung-T cells : 33.33% ; Lung-Ciliated cells : 24.34% ; Lung-Secretory cells : 31.87% ; Lung-ATI : 28.70% ; Lung-ATII : 17.90% ; Lung-Fibroblasts : 15.39% ; Lung-Ciliated cells : 14.34% ; Lung-Fibroblasts : 7.39% ; Lung-Macrophages : 5.78% ; Lung-Secretory cells : 3.98% ; |
|
Feline calicivirus |
Lung-Secretory cells : 44.44% ; Lung-ATI : 41.10% ; Lung-Ciliated cells : 40.92% ; Lung-Endothelial cells : 31.32% ; Lung-ATII : 30.59% ; |
|
Varicella Zoster Virus |
Lung-Secretory cells : 40.88% ; Lung-T cells : 33.33% ; Lung-Fibroblasts : 32.67% ; Lung-ATI : 24.10% ; Lung-Ciliated cells : 22.76% ; |
|
Human alphaherpesvirus 3 |
Lung-Secretory cells : 40.88% ; Lung-T cells : 33.33% ; Lung-Fibroblasts : 32.67% ; Lung-ATI : 24.10% ; Lung-Ciliated cells : 22.76% ; |
|
Ebola virus |
Lung-T cells : 33.33% ; Lung-Macrophages : 4.69% ; Lung-Macrophages : 25.94% ; Lung-Endothelial cells : 22.31% ; Lung-Fibroblasts : 16.89% ; Lung-Secretory cells : 10.59% ; Lung-Ciliated cells : 9.08% ; Lung-Macrophages : 25.23% ; Lung-Fibroblasts : 18.29% ; Lung-Secretory cells : 16.04% ; Lung-Ciliated cells : 11.05% ; Lung-ATI : 10.85% ; Lung-Macrophages : 11.80% ; Lung-Fibroblasts : 7.04% ; |
|
Japanese encephalitis virus |
Lung-T cells : 33.33% ; Lung-Macrophages : 4.69% ; |
|
Polytropic murine leukemia virus |
Lung-T cells : 33.33% ; Lung-Fibroblasts : 32.76% ; Lung-Ciliated cells : 22.24% ; Lung-Secretory cells : 21.07% ; Lung-Endothelial cells : 20.77% ; |
|
Lymphocytic choriomeningitis mammarenavirus | |
|
Feline leukemia virus strain C/FA27 |
Lung-T cells : 33.33% ; Lung-Fibroblasts : 11.43% ; Lung-Secretory cells : 8.60% ; Lung-ATI : 7.00% ; Lung-Ciliated cells : 6.97% ; |
|
Lassa mammarenavirus |
Lung-T cells : 33.33% ; Lung-Macrophages : 4.69% ; Lung-Secretory cells : 26.10% ; Lung-ATI : 19.50% ; Lung-Fibroblasts : 18.43% ; Lung-Ciliated cells : 16.58% ; Lung-ATII : 12.21% ; Lung-Macrophages : 11.80% ; Lung-Fibroblasts : 7.04% ; Lung-Fibroblasts : 5.58% ; Lung-Macrophages : 5.39% ; Lung-Secretory cells : 5.35% ; Lung-Ciliated cells : 3.95% ; |
|
SARS coronavirus |
Lung-T cells : 33.33% ; Lung-Macrophages : 4.69% ; |
|
Xenotropic murine leukemia virus |
Lung-T cells : 33.33% ; Lung-Fibroblasts : 32.76% ; Lung-Ciliated cells : 22.24% ; Lung-Secretory cells : 21.07% ; Lung-Endothelial cells : 20.77% ; |
|
Dengue virus |
Lung-T cells : 33.33% ; Lung-Secretory cells : 18.97% ; Lung-ATI : 11.15% ; Lung-ATII : 6.07% ; Lung-Ciliated cells : 5.79% ; Lung-Macrophages : 11.80% ; Lung-Fibroblasts : 7.04% ; Lung-Fibroblasts : 8.53% ; Lung-Secretory cells : 8.39% ; Lung-ATI : 6.90% ; Lung-ATII : 6.59% ; Lung-Endothelial cells : 6.15% ; |
|
Human mastadenovirus D |
Lung-Secretory cells : 31.87% ; Lung-ATI : 28.70% ; Lung-ATII : 17.90% ; Lung-Fibroblasts : 15.39% ; Lung-Ciliated cells : 14.34% ; |
|
Coxsackievirus B6 |
Lung-Secretory cells : 31.87% ; Lung-ATI : 28.70% ; Lung-ATII : 17.90% ; Lung-Fibroblasts : 15.39% ; Lung-Ciliated cells : 14.34% ; |
|
Human mastadenovirus E |
Lung-Secretory cells : 31.87% ; Lung-ATI : 28.70% ; Lung-ATII : 17.90% ; Lung-Fibroblasts : 15.39% ; Lung-Ciliated cells : 14.34% ; |
|
Coxsackievirus B4 |
Lung-Secretory cells : 31.87% ; Lung-ATI : 28.70% ; Lung-ATII : 17.90% ; Lung-Fibroblasts : 15.39% ; Lung-Ciliated cells : 14.34% ; |
|
Human mastadenovirus A |
Lung-Secretory cells : 31.87% ; Lung-ATI : 28.70% ; Lung-ATII : 17.90% ; Lung-Fibroblasts : 15.39% ; Lung-Ciliated cells : 14.34% ; |
|
Human mastadenovirus F |
Lung-Secretory cells : 31.87% ; Lung-ATI : 28.70% ; Lung-ATII : 17.90% ; Lung-Fibroblasts : 15.39% ; Lung-Ciliated cells : 14.34% ; |
|
Coxsackievirus B2 |
Lung-Secretory cells : 31.87% ; Lung-ATI : 28.70% ; Lung-ATII : 17.90% ; Lung-Fibroblasts : 15.39% ; Lung-Ciliated cells : 14.34% ; |
|
Hepatitis E virus |
Lung-Secretory cells : 29.98% ; Lung-ATI : 24.55% ; Lung-ATII : 14.00% ; Lung-Fibroblasts : 13.54% ; Lung-B cells : 11.70% ; |
|
Latino mammarenavirus |
Lung-Secretory cells : 26.10% ; Lung-ATI : 19.50% ; Lung-Fibroblasts : 18.43% ; Lung-Ciliated cells : 16.58% ; Lung-ATII : 12.21% ; |
|
Oliveros mammarenavirus |
Lung-Secretory cells : 26.10% ; Lung-ATI : 19.50% ; Lung-Fibroblasts : 18.43% ; Lung-Ciliated cells : 16.58% ; Lung-ATII : 12.21% ; |
|
Marburg marburgvirus | |
|
Human papillomavirus type 16 |
Lung-Macrophages : 22.58% ; Lung-Ciliated cells : 15.00% ; Lung-Endothelial cells : 13.75% ; Lung-Fibroblasts : 10.60% ; Lung-Secretory cells : 8.18% ; |
|
Middle East respiratory syndrome-related coronavirus |
Lung-Endothelial cells : 17.26% ; Lung-Fibroblasts : 7.78% ; Lung-Secretory cells : 5.03% ; |
|
Human rhinovirus A2 |
Lung-Secretory cells : 16.56% ; Lung-Fibroblasts : 9.15% ; Lung-ATI : 6.55% ; Lung-ATII : 5.44% ; Lung-Macrophages : 5.31% ; |
|
Sin Nombre orthohantavirus |
Lung-Secretory cells : 15.41% ; Lung-Endothelial cells : 11.75% ; Lung-ATI : 10.65% ; Lung-Fibroblasts : 10.16% ; Lung-Ciliated cells : 9.08% ; |
|
Andes orthohantavirus |
Lung-Secretory cells : 15.41% ; Lung-Endothelial cells : 11.75% ; Lung-ATI : 10.65% ; Lung-Fibroblasts : 10.16% ; Lung-Ciliated cells : 9.08% ; |
|
Bovine leukemia virus |
Lung-Secretory cells : 11.95% ; Lung-Fibroblasts : 11.83% ; Lung-ATI : 9.30% ; Lung-Macrophages : 8.05% ; Lung-Ciliated cells : 6.71% ; |
|
Zika virus |
Lung-Macrophages : 11.80% ; Lung-Fibroblasts : 7.04% ; |
|
Gibbon ape leukemia virus | |
|
Simian sarcoma-associated virus |
Lung-Secretory cells : 9.01% ; Lung-Fibroblasts : 8.97% ; Lung-ATI : 7.10% ; Lung-Ciliated cells : 6.58% ; Lung-Macrophages : 5.47% ; |
|
Feline leukemia virus strain B/lambda-B1 | |
|
Classical swine fever virus |
Lung-Fibroblasts : 8.53% ; Lung-Secretory cells : 8.39% ; Lung-ATI : 6.90% ; Lung-ATII : 6.59% ; Lung-Endothelial cells : 6.15% ; |
|
Adeno-associated virus 9 |
Lung-Fibroblasts : 8.53% ; Lung-Secretory cells : 8.39% ; Lung-ATI : 6.90% ; Lung-ATII : 6.59% ; Lung-Endothelial cells : 6.15% ; |
|
Sindbis virus |
Lung-Fibroblasts : 8.53% ; Lung-Secretory cells : 8.39% ; Lung-ATI : 6.90% ; Lung-ATII : 6.59% ; Lung-Endothelial cells : 6.15% ; |
|
Adeno-associated virus - 3 |
Lung-Fibroblasts : 8.53% ; Lung-Secretory cells : 8.39% ; Lung-ATI : 6.90% ; Lung-ATII : 6.59% ; Lung-Endothelial cells : 6.15% ; |
|
Adeno-associated virus - 8 |
Lung-Fibroblasts : 8.53% ; Lung-Secretory cells : 8.39% ; Lung-ATI : 6.90% ; Lung-ATII : 6.59% ; Lung-Endothelial cells : 6.15% ; |
|
Venezuelan equine encephalitis virus |
Lung-Fibroblasts : 8.53% ; Lung-Secretory cells : 8.39% ; Lung-ATI : 6.90% ; Lung-ATII : 6.59% ; Lung-Endothelial cells : 6.15% ; |
|
Baboon endogenous virus strain M7 |
Lung-Fibroblasts : 8.05% ; Lung-Macrophages : 6.41% ; Lung-Secretory cells : 5.66% ; |
|
Feline endogenous virus RD114 |
Lung-Fibroblasts : 8.05% ; Lung-Macrophages : 6.41% ; Lung-Secretory cells : 5.66% ; |
|
Simian type D retrovirus -Tsukuba |
Lung-Fibroblasts : 8.05% ; Lung-Macrophages : 6.41% ; Lung-Secretory cells : 5.66% ; |
|
Amphotropic murine leukemia virus |
Lung-Secretory cells : 7.97% ; Lung-Fibroblasts : 6.64% ; Lung-Ciliated cells : 6.32% ; Lung-ATI : 6.05% ; |
|
Machupo mammarenavirus |
Lung-Macrophages : 7.03% ; Lung-Secretory cells : 6.81% ; Lung-Fibroblasts : 6.55% ; Lung-ATI : 3.85% ; |
|
Argentinian mammarenavirus |
Lung-Macrophages : 7.03% ; Lung-Secretory cells : 6.81% ; Lung-Fibroblasts : 6.55% ; Lung-ATI : 3.85% ; |
|
Canine parvovirus |
Lung-Macrophages : 7.03% ; Lung-Secretory cells : 6.81% ; Lung-Fibroblasts : 6.55% ; Lung-ATI : 3.85% ; |
|
Mouse mammary tumor virus |
Lung-Macrophages : 7.03% ; Lung-Secretory cells : 6.81% ; Lung-Fibroblasts : 6.55% ; |
|
Guanarito mammarenavirus |
Lung-Macrophages : 7.03% ; Lung-Secretory cells : 6.81% ; Lung-Fibroblasts : 6.55% ; Lung-ATI : 3.85% ; |
|
Feline panleukopenia virus |
Lung-Macrophages : 7.03% ; Lung-Secretory cells : 6.81% ; Lung-Fibroblasts : 6.55% ; Lung-ATI : 3.85% ; |
|
Rabies lyssavirus |
Lung-Fibroblasts : 5.41% ; |
|
Jaagsiekte sheep retrovirus |
Lung-Endothelial cells : 5.02% ; |
|
Human mastadenovirus B |
Lung-Macrophages : 4.69% ; |